AG
Adam Greene
OtherActivePartner at Deerfield Management
New York, United StatesFounded 2019
80
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Adam Greene.
Investment Thesis & Strategy
Deerfield Management invests in various stages of biotech, healthcare, health & hospital services, health IT, and pharmaceutical companies, seeking to support innovative solutions in the healthcare industry.
Portfolio Companies
Selected investments from their portfolio of 80 companies
G
Global Blood Therapeutics
Biotech · Series C+, 0
S
Spark Therapeutics
Biotech · Series C+, 0
T
TESARO
Biotech · Growth, 0
K
Kolltan Pharmaceuticals
Biotech · Series A, 0
A
Aralez Pharmaceuticals
Biotech · Growth, 0
S
Shockwave Medical
Healthcare · Series C+, 0
A
Assertio
Biotech · Growth, 0
V
Vital Access
Healthcare · Seed, 0
M
MannKind
Biotech · Growth, 0
D
Dracen Pharmaceuticals
Biotech · Seed, 0
L
LetsGetChecked
Healthcare · Series A, 0
S
SteadyMed Therapeutics
Biotech · Series B, 0
Frequently Asked Questions
Adam Greene focuses on Series B stage investments.